For example, Zhao et al. (98) validated an ARDS-mortality prediction model, including the age, surfactant protein D, and interleukin-8, which may be useful for risk assessment in clinical trial enrollment. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.